ALK Inhibitors: Products

Anaplastic Lymphoma Kinase (ALK), also known as CD246, is a 220 kDa transmembrane glycoprotein that is primarily expressed in the developing nervous system. ALK contains one LDL Receptor (LDLR) class A domain, two meprin/A5-protein/PTPmu (MAM) domains, and a cytoplasmic kinase domain.

"ALK Inhibitors" has 6 results in Products.
Sort by:
Results Per Page:

KRCA 0008 

Potent Ack1 and ALK dual inhibitor; orally bioavailable

GSK 1838705 

Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma kinase (ALK)

ASP 3026 

Potent anaplastic lymphoma kinase (ALK) inhibitor; also potent ACK inhibitor

LDN 212854 

Potent bone morphogenetic protein type I (ALK) inhibitor


Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3


Potent c-MET/ALK inhibitor
page of 1
Back to Search Results
FiltersClear All